ERBB2 and breast cancer: This hypothesis is independently supported by the notion that the promoter regions of ITGA4 and ITGA9 genes, the two α-integrins responsible for EMILIN1 cellular binding, are hypermethylated in BC, particularly in HER2+ tumors35.